ArticleBMC biology2026
A novel method for drug-target affinity prediction by integrating predicted evolutionary information and multi-scale protein graphs.
Article in BMC biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundDrug-target affinity (DTA) prediction is crucial for drug discovery. While protein evolutionary features are vital for identifying conserved regions, current methods rely on computationally expensive multiple sequence alignment (MSA), creating a significant bottleneck. To address this, we propose MAFI-DTA, a novel model that circumvents the computational burden of MSA by deriving evolutionary context directly from sequences using the advanced protein language model, ESM-3. Furthermore, we introduced a multi-scale protein graph construction strategy based on varying numbers of residues, enabling the effective extraction of structural information across different scales through a neural network integrating graph neural networks, BiLSTM, and transformer modules.
resultsExperimental validation on multiple benchmark datasets demonstrates that MAFI-DTA achieves significantly better performance compared to existing approaches. This improved accuracy is attributed to the effective incorporation of both the predicted evolutionary information and the multi-scale graph representations. The source code is available at https://github.com/aliveadult/MAFI .
conclusionsMAFI-DTA successfully captures crucial evolutionary and multi-scale structural context efficiently, overcoming the limitations of traditional MSA methods. This approach provides a high-performing tool that facilitates the study of drug-target interactions and accelerates the drug discovery process.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.